Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01115777 · ClinicalTrials.gov registry record
Prospective Assessment of Quality of Life (QOL) in Pediatric Patients Treated With Radiation Therapy for Brain Tumors and Non-central Nervous System (Non-CNS) Malignancies
A clinical trial of Brain Tumors and Non-CNS Malignancies, sponsored by Massachusetts General Hospital.
- Active
- Registry status
- 600
- Enrollment target
- 1
- Study location
NCT01115777 is a study of Brain Tumors and Non-CNS Malignancies that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 600 participants, below the 6,283-participant average among 10 other Brain Tumors trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01115777, a study of Brain Tumors and Non-CNS Malignancies, is active but no longer recruiting, sponsored by Massachusetts General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- 600 participants
- Enrollment target
- 1
- Study location
Study Summary
In recent years, remarkable advances in medical oncology, surgery, and radiology have allowed for increasing cure rates for childhood malignancies. This success has led to an emerging understanding of the kinds of effects that treatments can have on the pediatric population and how such effects can influence pediatric cancer survivor's functioning and quality of life. It has become tremendously important to assess the long-term complications due to therapy in this growing sector of survivors and to tailor our treatments so as to minimize these late effects. The Investigators at MGH are committed to improving the delivery of radiotherapy to our patients and improving the outcome for these patients. MGH has an on-site cyclotron for proton radiotherapy in order to provide the most advanced care for patients in need. Proton therapy possesses a clinical advantage over standard photon therapy in that its optimal dose distribution delivers the bulk of radiation to the tumor site. This method spares the greatest volume of normal tissue, resulting in decreased short-term and long-term morbidity. Through open pediatric protocols for patients treated with proton radiotherapy, the investigators aim to define and report the acute and late effects associated with treatment. The investigators also treat a number of patients off-protocol with both proton and photon radiotherapy, and are interested in reporting these patients' QOL outcomes in conjunction with other clinical data that may be pertinent to the site of tumor treatment. This research is significant in that it will allow us to delineate the positive and negative effects of radiation treatment on patients' QOL, highlighting points of success and exposing areas that are in need of improvement. Such knowledge will be used to improve the experience of pediatric cancer survivors in the future. The aims of this study are: 1) to prospectively collect and report the QOL outcomes in patients treated with radiotherapy and 2) to
Conditions Studied
Interventions
- OTHER Quality of Life surveys completed at specified timepoints
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2005-09 |
| Est. Completion | 2029-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01115777
The ClinicalTrials.gov registry entry for NCT01115777 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,283-participant average among 10 other Brain Tumors trials with a reported enrollment target (90% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Brain Tumors appearing as the primary indexed condition, and to 1 intervention - of which Quality of Life surveys completed at specified timepoints is the first listed.
NCT01115777 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01115777 about?
NCT01115777 is a clinical study titled "Prospective Assessment of Quality of Life (QOL) in Pediatric Patients Treated With Radiation Therapy for Brain Tumors and Non-central Nervous System (Non-CNS) Malignancies". In recent years, remarkable advances in medical oncology, surgery, and radiology have allowed for increasing cure rates for childhood malignancies. This success has led to an emerging understanding of the kinds of effects that treatments can have on the pediatric population and how such effects can ...
What is the current status of trial NCT01115777?
This trial is currently active not recruiting. The enrollment target is 600 participants. The study started on 2005-09. Estimated completion is 2029-03.
What conditions does trial NCT01115777 study?
This clinical trial studies the following conditions: Brain Tumors, Non-CNS Malignancies.
What interventions are being tested in trial NCT01115777?
The interventions under investigation include: Quality of Life surveys completed at specified timepoints (OTHER).
Who is sponsoring clinical trial NCT01115777?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01115777 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Tumors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Florida Center for Brain Tumor Research
RECRUITING
-
Blood Flow MRI for Monitoring Brain Tumors
ACTIVE NOT RECRUITING
-
Enrollment on the Childhood Cancer Research Network (CCRN) of the Children's Oncology Group
ACTIVE NOT RECRUITING
-
ALA-induced PpIX Fluorescence During Brain Tumor Resection
ACTIVE NOT RECRUITING · Phase 1
-
Study of Systemic and Spinal Chemotherapy Followed by Radiation for Infants With Brain Tumors
COMPLETED · NA
-
[F-18] Fluorothymidine (FLT) Imaging on Patients With Primary Brain Tumors
COMPLETED · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.